Fox Business - The Power to Prosper
Search Site

Wednesday, April 7, 2010 as of 11:14 AM ET

GlaxoSmithKline

More Headlines »« Less Headlines

GlaxoSmithKline plc (GSK) (, ) is a British multinational pharmaceutical, biologics, vaccines, and consumer healthcare company headquartered in London, United Kingdom.

Read More at Wikipedia ›

Related Topics

  1. AstraZeneca
  2. London Stock Exchange
  3. Pharmaceuticals
  4. Smith & Nephew Plc
  5. Xstrata Plc
  6. Tesco Plc
Get updates on GlaxoSmithKline
GlaxoSmithKline Buys For Treasury 1.8 Million Shares

GlaxoSmithKline PLC (GSK.

LN) said Friday that it bought for treasury 1.8 million shares at a highest price of 1,427.5 pence and a lowest price of 1,409.0 pence.Copyright © 2012 Dow Jones Newswires...

Read More ›

  1. Drugmakers Assess Contingency Plan For Greece

    Global drug companies are working with European authorities on how to keep medicines flowing into Greece if the country is forced out of the region's single currency...

  2. GlaxoSmithKline Buys Back 1.6 Million Shares

    GlaxoSmithKline PLC (GSK.LN) Friday said it purchased 1.6 million ordinary shares on May 18.MAIN FACTS:-Highest price paid per share was 1410 pence per share.-Lowest...

  3. Report: Drug Makers Working on Emergency Supply Plan in Greece

    Major drug makers are reportedly working with European authorities on an emergency plan that would keep medicines flowing to Greece if the embattled country exits th...

  4. ADR Report: Shares Lower As Euro-Zone Worries Loom

    International companies trading in New York ended lower Thursday, in line with the broader market, as continued worries about Greece and concerns about the health of...

  5. GlaxoSmithKline Offer To Acquire HGS Represents Full, Fair Value

    GlaxoSmithKline PLC (GSK.LN), a British pharmaceutical company, said Thursday it believes its tender offer for Human Genome Sciences(HGSI) represents full and fair v...

  6. GlaxoSmithKline PLC GSK statement on tender offer to acquire HGS

    TIDMGSKRNS Number : 6205DGlaxoSmithKline PLC17 May 2012Issued: Thursday 17 May 2012, London UK - LSE AnnouncementGSK statement on tender offer to acquire Human Genom...

  7. Human Genome Adopts 'Poison Pill' to Defend Against Glaxo

    Human Genome Sciences (NASDSAQ:HGSI) has adopted a stockholder rights plan - known widely as a "poison pill" defense strategy - in an effort to protect itself from a...

  8. Human Genome Adopts Poison Pill With 15% Trigger To Deter Glaxo

    Human Genome Sciences Inc. (HGSI) adopted a shareholder rights plan with a 15% trigger in the wake of GlaxoSmithKline PLC's (GSK, GSK.LN) $2.6 billion hostile takeov...

  9. GlaxoSmithKline Buys Back 1.2 Million Shares

    GlaxoSmithKline PLC (GSK.LN) Wednesday said it purchased 1.2 million ordinary shares on May 16.MAIN FACTS:-Highest price paid per share was 1427.5 pence per share.-L...

  10. GlaxoSmithKline Completes Acquisition Of 10 Million Theravance Shares

    Drug group GlaxoSmithKline PLC (GSK.LN) said Wednesday that its acquisition of 10 million shares of biopharmaceutical firm Theravance's (THRX) common stock has now c...

  11. GlaxoSmithKline Buys Back 1.4 Million Shares For Treasury

    GlaxoSmithKline PLC (GSK.LN) Tuesday said it purchased 1.4 million ordinary shares, to hold in Treasury, on May 15.MAIN FACTS:-Highest price paid per share was 1425 ...

  12. GlaxoSmithKline To Buy Remaining 80.02% Of Cellzome For GBP61 Million

    Research-based pharmaceutical and healthcare company GlaxoSmithKline PLC (GSK.LN) said Tuesday it has entered into an agreement to buy the 80.02% of Cellzome AG it d...

  1. GlaxoSmithKline : CHMP Recommends Authorization For Pazopanib

    GlaxoSmithKline PLC (GSK.LN), the pharmaceutical company, said Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued ...

  2. GlaxoSmithKline Buys Back 1.8 Million Own Shares To Hold In Treasury

    GlaxoSmithKline PLC (GSK.LN), a research-based pharmaceutical and healthcare company, said Thursday it purchased 1.8 million of its Ordinary Shares of 25 pence each,...

  3. GlaxoSmithKline Buys Back 1.8 Million Shares For Treasury

    GlaxoSmithKline PLC said Wednesday it bought 1,800,000 of its own ordinary shares to hold in treasury, with the highest price paid 1,409.0 pence per share and the lo...

  4. Glaxo Amends Offer To Address HGS Shareholder Rights Plan

    U.K. listed pharmaceutical giant GlaxoSmithKline PLC (GSK.LN) Wednesday said it has amended the conditions of the tender offer to acquire Human Genome Sciences (HGSI...

  5. GlaxoSmithKline PLC GSK amends HGS tender offer conditions

    TIDMGSKRNS Number : 9539DGlaxoSmithKline PLC23 May 2012Issued: Wednesday 23 May 2012, London UKGSK amends tender offer conditions to address Human Genome Sciences' a...

  6. Auxilium To Promote Testosterone Gel With Glaxo; Raises View

    Auxilium Pharmaceuticals Inc. (AUXL) raised its full-year outlook as it entered an agreement with the U.S. unit of GlaxoSmithKline PLC (GSK) to co-promote a testoste...

  7. Auxilium Pharma, Not GlaxoSmithKline , Issued Certain Guidance Information

    Auxilium Pharmaceuticals Inc. issued certain guidance information related to their 2012 financial performance and co-promotion agreement with GlaxoSmithKline.(Earlie...

‹ Prev12345…Next ›
Freebase CC-BY
Source: GlaxoSmithKline on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL